These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 26923466

  • 21. Treatment plan evaluation using dose-volume histogram (DVH) and spatial dose-volume histogram (zDVH).
    Cheng CW, Das IJ.
    Int J Radiat Oncol Biol Phys; 1999 Mar 15; 43(5):1143-50. PubMed ID: 10192366
    [Abstract] [Full Text] [Related]

  • 22. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST, Hoogeman MS, Heemsbergen WD, Slot A, Tabak H, Koper PC, Lebesque JV.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1142-52. PubMed ID: 15939547
    [Abstract] [Full Text] [Related]

  • 23. A cylindrical model of the rectum: comparing dose-volume, dose-surface and dose-wall histograms in the radiotherapy of prostate cancer.
    Fiorino C, Gianolini S, Nahum AE.
    Phys Med Biol; 2003 Aug 21; 48(16):2603-16. PubMed ID: 12974577
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
    Schwarz M, Lebesque JV, Mijnheer BJ, Damen EM.
    Radiother Oncol; 2004 Nov 21; 73(2):209-18. PubMed ID: 15542168
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1297-308. PubMed ID: 16029785
    [Abstract] [Full Text] [Related]

  • 27. Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancer.
    García-Vicente F, Zapatero A, Floriano A, Cruz-Conde A, Perez L, Marín A, Mínguez C, Torres JJ.
    Med Phys; 2005 Aug 01; 32(8):2503-9. PubMed ID: 16193780
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
    Yuan L, Ge Y, Lee WR, Yin FF, Kirkpatrick JP, Wu QJ.
    Med Phys; 2012 Nov 01; 39(11):6868-78. PubMed ID: 23127079
    [Abstract] [Full Text] [Related]

  • 30. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A, Töws N, Schmidberger H, Hess CF.
    Strahlenther Onkol; 2005 Dec 01; 181(12):789-95. PubMed ID: 16362789
    [Abstract] [Full Text] [Related]

  • 31. Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy.
    Hamlett LJ, McPartlin AJ, Maile EJ, Webster G, Swindell R, Rowbottom CG, Choudhury A, Aitkenhead AH.
    Br J Radiol; 2015 Oct 01; 88(1054):20150110. PubMed ID: 26246172
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Vesprini D, Sia M, Lockwood G, Moseley D, Rosewall T, Bayley A, Bristow R, Chung P, Ménard C, Milosevic M, Warde P, Catton C.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e415-21. PubMed ID: 21477939
    [Abstract] [Full Text] [Related]

  • 34. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):763-72. PubMed ID: 20171807
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
    Reddy NM, Nori D, Chang H, Lange CS, Ravi A.
    Med Phys; 2010 Jul 01; 37(7):3791-801. PubMed ID: 20831087
    [Abstract] [Full Text] [Related]

  • 37. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):141-9. PubMed ID: 16111582
    [Abstract] [Full Text] [Related]

  • 38. Dose-wall histograms and normalized dose-surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy.
    Meijer GJ, van den Brink M, Hoogeman MS, Meinders J, Lebesque JV.
    Int J Radiat Oncol Biol Phys; 1999 Nov 01; 45(4):1073-80. PubMed ID: 10571217
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.
    Boehmer D, Kuczer D, Badakhshi H, Stiefel S, Kuschke W, Wernecke KD, Budach V.
    Strahlenther Onkol; 2006 May 01; 182(5):277-82. PubMed ID: 16673061
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.